Regulation of cardiomyocyte full-length tissue factor expression and microparticle release under inflammatory conditions in vitro

J Thromb Haemost. 2009 May;7(5):871-8. doi: 10.1111/j.1538-7836.2009.03323.x. Epub 2009 Feb 18.

Abstract

Summary background: Myocardial inflammation is associated with an increase in circulating microparticles (MPs) and procoagulability.

Objectives: We determined whether acute inflammation was associated with altered full-length tissue factor (flTF) expression and increased procoagulability in cardiomyocytic cells.

Methods: This study examined the transcriptional regulation of flTF expression in murine cardiomyocytic (HL-1) cells. Also, the generation of MPs by HL-1 cells and their ability to diffuse through an artificial endothelium was evaluated.

Results: Constitutive and tumor necrosis factor-alpha (TNF-alpha)-induced flTF expression of HL-1 was reduced when c-Jun N-terminal kinase (JNK) was inhibited. Tissue factor (TF)-positive procoagulant MPs were released from HL-1 cells in response to TNF-alpha. JNK inhibition potentiated the release of MPs from HL-1 cells without affecting MP-associated TF activity. MP generation was dependent on RhoA activation and associated with a reorganization of the actin cytoskeleton. Increased diffusion of HL-1-derived MPs through an endothelial monolayer was found after TNF-alpha treatment. The increased diffusion was dependent not only on TNF-alpha but also on HL-1-released mediators.

Conclusions: Full-length TF expression in HL-1 cells was regulated through JNK. The TNF-alpha-induced increase in procoagulability was mediated through RhoA-dependent release of flTF-bearing MPs. These MPs were able to diffuse through an endothelial barrier adjacent to HL-1 cells and increased the procoagulability of the extracellular endothelial space. Cardiomyocytes seem to be a likely source of flTF-bearing procoagulant MPs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / metabolism
  • Animals
  • Cell Line
  • Coculture Techniques
  • Inflammation / metabolism*
  • Mice
  • Myocardium / metabolism*
  • Polymerase Chain Reaction
  • RNA, Messenger / genetics
  • Thromboplastin / genetics
  • Thromboplastin / metabolism*
  • Transcription, Genetic
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • Actins
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha
  • Thromboplastin